<DOC>
	<DOCNO>NCT02839876</DOCNO>
	<brief_summary>The purpose study determine intravenous acetaminophen superior oral acetaminophen use part multimodal pathway primary total hip arthroplasty .</brief_summary>
	<brief_title>Intravenous Versus Oral Acetaminophen Primary Total Hip Arthroplasty</brief_title>
	<detailed_description>This single center , prospective , randomize control study . 60 subject recruit ( see # 6 Recruitment Compensation ) . On day surgery , subject randomize receive either study intervention ( intravenous acetaminophen placebo tablet ) control intervention ( intravenous saline active acetaminophen tablet ) . The Investigational Drug Service prepare intervention package , include one intravenous one oral medication dose . Only one route active ( determined randomization ) . Subjects receive dos intravenous oral study drug every 6 hour order maintain blinding , receive total 4 dos ( 0 , 6 , 12 18 hour ) . The dose acetaminophen case 1000 mg . The volume intravenous acetaminophen ( saline ) 100 mL . The oral dose consist two ( 2 ) tablet 500 mg ( two match placebo tablet ) . All subject receive standardize anesthetic regimen total hip arthroplasty , follow : A ) Preoperative phase Subjects receive follow preoperative multimodal drug : - Pregabalin 75 mg PO - Celecoxib 200 mg PO - The interventional drug , IV PO . The time drug administer record time zero . Patients receive spinal anesthetic 12.5 mg isobaric bupivacaine . No peripheral nerve block perform . B ) Intraoperative phase All subject receive propofol infusion begin 50 mg/kg/min titrate Richmond Agitation-Sedation Scale score -1 -3 ( drowsy moderate sedation ) . Dexamethasone 10 mg IV ketamine 0.25 mg/kg IV 40 mg total administer part standard multimodal regimen . If require , subject may receive fentanyl 25 mcg IV need treat discomfort . No joint infiltration perform surgeon . C ) Postoperative phase In Post-Anesthesia Care Unit ( PACU ) , subject intravenous patient-controlled analgesia ( IVPCA ) device connect loading dos hydromorphone administer PACU nurse necessary ( 0.2 mg q 8 min prn ) . On floor , subject receive : - Pregabalin 75 mg PO BID discharge - Celecoxib 200 mg PO BID discharge - Dexamethasone 10 mg IV x 1 postoperative day 1 ( 24 hour first dose ) - Intravenous patient-controlled analgesia ( IVPCA ) hydromorphone ( 0.2 mg q 8 min ) . The remain 3 intervention package ( IV PO ) administer 6 , 12 18 hour follow first dose . At time point 24 hour ( i.e . fifth dose acetaminophen ) , subject begin receive 975 mg oral acetaminophen , continue every six hour discharge .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients schedule elective , primary total hip replacement osteoarthritis American Society Anesthesiologists ( ASA ) Physical Classification IIII Weight 50 kg great Body mass index 1840 kg/m2 Inability consent study Inability speak English Pregnancy Weight &lt; 50 kg Revision hip replacement emergency surgery Contraindications spinal anesthesia : coagulopathy bleed diathesis , local infection , allergy local anesthetic Allergies/intolerances/contraindications multimodal agent : acetaminophen , pregabalin , celecoxib , ketamine , dexamethasone Chronic pain separate source operative hip Daily opioid equivalent use 30 mg morphine great time consent History heart failure History drug alcohol abuse Rheumatoid arthritis Uncontrolled anxiety , schizophrenia psychiatric disorder , opinion investigator , may interfere study assessment Chronic malnutrition , renal liver impairment Hypersensitivity acetaminophen excipients</criteria>
	<gender>All</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>